Macrophage activation syndrome or septic arthritis: a case of mistaken identity

Gemma L Green1, Arash Aframian, Parthiban Vinayakam

  • 1aSt Georges Hospital, Tooting, London bQueen Elizabeth the Queen Mother Hospital, Margate, Kent, UK.

Insights

Macrophage activation syndrome (MAS) can mimic septic arthritis, posing diagnostic challenges, especially in pediatric cases. Early recognition and prompt treatment are crucial for improving outcomes in this underdiagnosed condition.

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Infectious Diseases
  • Critical Care Medicine

Background:

  • Macrophage activation syndrome (MAS) is a severe, life-threatening hyperinflammation.
  • It is often underdiagnosed and can be mistaken for other critical conditions like septic arthritis.
  • Prompt diagnosis and management are vital for patient survival.

Observation:

  • A case of MAS in a 2-year-old, initially misdiagnosed as septic arthritis, highlights diagnostic difficulties.
  • Similarities in clinical presentation between MAS and septic arthritis can lead to misdiagnosis.
  • Small hospital units face particular challenges in differentiating these conditions.

Findings:

  • A literature review was conducted to identify clinical, radiological, and epidemiological features of MAS.
  • A diagnostic algorithm was developed to aid in differentiating MAS from septic arthritis.
  • Current treatment recommendations, despite the lack of a set regimen, were compiled.

Implications:

  • This case underscores the diagnostic pitfalls in distinguishing MAS from septic arthritis.
  • Implementing a structured diagnostic approach can improve early identification of MAS.
  • Timely intervention in MAS is critical for optimizing patient prognosis and reducing mortality.